HAVCR2 and lung adenocarcinoma: Furthermore, in patients with lung adenocarcinoma, higher levels of Tim-3, but not other immune checkpoint markers, were detected in T cells from patients who had developed resistance to anti-PD-1 therapy [19], indicating the importance of Tim-3.